Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Burn

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
The Lancet Regional Health. Europe|February 9, 2026
Trends in use of Attention-Deficit Hyperactivity Disorder medications among children and adults in five European countries, 2010 to 2023: a population-based observational studyXintong Li, Yuchen Guo, Agustina Giuliodori Picco, et al.
Pharmacoepidemiology and Drug Safety|October 16, 2025
Secular Trends in the Use of Valproate-Containing Medicines in Women of Childbearing Age in Europe: A Multinational DARWIN EU Network StudyLucía Bellas, Martí Català, Edward Burn, et al.
Clinical Epidemiology|September 19, 2023
Transforming the Information System for Research in Primary Care (SIDIAP) in Catalonia to the OMOP Common Data Model and Its Use for COVID-19 ResearchBerta Raventós, Sergio Fernández-Bertolín, María Aragón, et al.
Pharmacoepidemiology and Drug Safety|October 25, 2023
IncidencePrevalence: An R package to calculate population-level incidence rates and prevalence using the OMOP common data modelBerta Raventós, Martí Català, Mike Du, et al.
Age and Ageing|June 24, 2026
Prescription cascades associated with acetylcholinesterase inhibitors use: a high-throughput sequence symmetry analysisDanielle Newby, Sai Sumedha Bobba, Berta Raventós, et al.
Frontiers in Pharmacology|April 10, 2023
Characterising the treatment of thromboembolic events after COVID-19 vaccination in 4 European countries and the US: An international network cohort studyAniek F Markus, Victoria Y Strauss, Edward Burn, et al.
BMJ (Clinical Research Ed.)|October 26, 2022
Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the USXintong Li, Edward Burn, Talita Duarte-Salles, et al.
The Lancet. Respiratory Medicine|January 14, 2024
The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and EstoniaMartí Català, Núria Mercadé-Besora, Raivo Kolde, et al.
Clinical Epidemiology|June 17, 2024
The Impact of the COVID-19 Pandemic on Incidence and Short-Term Survival for Common Solid Tumours in the United Kingdom: A Cohort AnalysisNicola L Barclay, Theresa Burkard, Edward Burn, et al.
Pharmacoepidemiology and Drug Safety|July 14, 2026
DrugUtilisation: An R Package to Support Drug Utilisation Research Using the OMOP Common Data ModelYuchen Guo, Edward Burn, Annika M Jödicke, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
The Lancet Regional Health. Europe|February 9, 2026
Trends in use of Attention-Deficit Hyperactivity Disorder medications among children and adults in five European countries, 2010 to 2023: a population-based observational studyXintong Li, Yuchen Guo, Agustina Giuliodori Picco, et al.
Pharmacoepidemiology and Drug Safety|October 16, 2025
Secular Trends in the Use of Valproate-Containing Medicines in Women of Childbearing Age in Europe: A Multinational DARWIN EU Network StudyLucía Bellas, Martí Català, Edward Burn, et al.
Clinical Epidemiology|September 19, 2023
Transforming the Information System for Research in Primary Care (SIDIAP) in Catalonia to the OMOP Common Data Model and Its Use for COVID-19 ResearchBerta Raventós, Sergio Fernández-Bertolín, María Aragón, et al.
Pharmacoepidemiology and Drug Safety|October 25, 2023
IncidencePrevalence: An R package to calculate population-level incidence rates and prevalence using the OMOP common data modelBerta Raventós, Martí Català, Mike Du, et al.
Age and Ageing|June 24, 2026
Prescription cascades associated with acetylcholinesterase inhibitors use: a high-throughput sequence symmetry analysisDanielle Newby, Sai Sumedha Bobba, Berta Raventós, et al.
Frontiers in Pharmacology|April 10, 2023
Characterising the treatment of thromboembolic events after COVID-19 vaccination in 4 European countries and the US: An international network cohort studyAniek F Markus, Victoria Y Strauss, Edward Burn, et al.
BMJ (Clinical Research Ed.)|October 26, 2022
Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the USXintong Li, Edward Burn, Talita Duarte-Salles, et al.
The Lancet. Respiratory Medicine|January 14, 2024
The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and EstoniaMartí Català, Núria Mercadé-Besora, Raivo Kolde, et al.
Clinical Epidemiology|June 17, 2024
The Impact of the COVID-19 Pandemic on Incidence and Short-Term Survival for Common Solid Tumours in the United Kingdom: A Cohort AnalysisNicola L Barclay, Theresa Burkard, Edward Burn, et al.
Pharmacoepidemiology and Drug Safety|July 14, 2026
DrugUtilisation: An R Package to Support Drug Utilisation Research Using the OMOP Common Data ModelYuchen Guo, Edward Burn, Annika M Jödicke, et al.
Pageof 8